IL133075A0 - Gelatine encapsulated solution dosage forms of sertraline - Google Patents

Gelatine encapsulated solution dosage forms of sertraline

Info

Publication number
IL133075A0
IL133075A0 IL13307598A IL13307598A IL133075A0 IL 133075 A0 IL133075 A0 IL 133075A0 IL 13307598 A IL13307598 A IL 13307598A IL 13307598 A IL13307598 A IL 13307598A IL 133075 A0 IL133075 A0 IL 133075A0
Authority
IL
Israel
Prior art keywords
sertraline
dosage forms
solution dosage
encapsulated solution
gelatine encapsulated
Prior art date
Application number
IL13307598A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133075(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL133075A0 publication Critical patent/IL133075A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL13307598A 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline IL133075A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (1)

Publication Number Publication Date
IL133075A0 true IL133075A0 (en) 2001-03-19

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13307598A IL133075A0 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Country Status (40)

Country Link
EP (1) EP0980241B1 (xx)
JP (1) JP3585245B2 (xx)
KR (1) KR100371730B1 (xx)
CN (1) CN1261792A (xx)
AP (1) AP945A (xx)
AR (1) AR015916A1 (xx)
AT (1) ATE256457T1 (xx)
AU (1) AU724635B2 (xx)
BG (1) BG103917A (xx)
BR (1) BR9809712A (xx)
CA (1) CA2290973C (xx)
CO (1) CO4940405A1 (xx)
DE (1) DE69820608T2 (xx)
DK (1) DK0980241T3 (xx)
DZ (1) DZ2544A1 (xx)
EA (1) EA001905B1 (xx)
ES (1) ES2210760T3 (xx)
GT (1) GT199800090A (xx)
HR (1) HRP980378B1 (xx)
HU (1) HUP0002250A3 (xx)
ID (1) ID24673A (xx)
IL (1) IL133075A0 (xx)
IS (1) IS5266A (xx)
MA (1) MA24586A1 (xx)
MY (1) MY119728A (xx)
NO (1) NO996492L (xx)
NZ (1) NZ501252A (xx)
OA (1) OA11246A (xx)
PA (1) PA8454001A1 (xx)
PE (1) PE97299A1 (xx)
PL (1) PL337807A1 (xx)
PT (1) PT980241E (xx)
SK (1) SK282914B6 (xx)
TN (1) TNSN98123A1 (xx)
TR (1) TR199903282T2 (xx)
TW (1) TW382597B (xx)
UA (1) UA68350C2 (xx)
UY (1) UY25070A1 (xx)
WO (1) WO1999001113A1 (xx)
ZA (1) ZA985709B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
HUP0104470A3 (en) * 1998-10-13 2003-12-29 Pfizer Prod Inc Sertraline oral concentrate and process for its preparation
DE60026146T2 (de) 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
US20040142040A1 (en) * 2002-10-31 2004-07-22 Dong Liang C. Formulation and dosage form providing increased bioavailability of hydrophobic drugs
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214276T1 (de) * 1994-09-19 2002-03-15 Du Pont Pharm Co Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
PT768083E (pt) * 1995-07-17 2003-08-29 Pfizer Sertralina para o tratamento de doentes pos-enfarte miocardico

Also Published As

Publication number Publication date
EP0980241A1 (en) 2000-02-23
NZ501252A (en) 2004-11-26
UY25070A1 (es) 2000-12-29
IS5266A (is) 1999-11-23
KR100371730B1 (ko) 2003-02-07
AP9801279A0 (en) 1998-06-30
NO996492D0 (no) 1999-12-27
PL337807A1 (en) 2000-09-11
OA11246A (en) 2002-11-19
JP2000512316A (ja) 2000-09-19
AR015916A1 (es) 2001-05-30
GT199800090A (es) 1999-12-21
JP3585245B2 (ja) 2004-11-04
WO1999001113A1 (en) 1999-01-14
PE97299A1 (es) 1999-10-13
CA2290973A1 (en) 1999-01-14
DE69820608T2 (de) 2004-12-23
ATE256457T1 (de) 2004-01-15
SK180599A3 (en) 2001-01-18
CA2290973C (en) 2003-06-17
ES2210760T3 (es) 2004-07-01
EA001905B1 (ru) 2001-10-22
HUP0002250A3 (en) 2001-01-29
EP0980241B1 (en) 2003-12-17
EA199900963A1 (ru) 2000-08-28
PA8454001A1 (es) 2000-05-24
KR20010013588A (ko) 2001-02-26
TW382597B (en) 2000-02-21
MA24586A1 (fr) 1998-12-31
AU724635B2 (en) 2000-09-28
AU7545098A (en) 1999-01-25
ZA985709B (en) 2000-01-10
CN1261792A (zh) 2000-08-02
SK282914B6 (sk) 2003-01-09
BR9809712A (pt) 2000-07-11
TNSN98123A1 (fr) 2005-03-15
MY119728A (en) 2005-07-29
AP945A (en) 2001-02-28
HRP980378B1 (en) 2001-12-31
DK0980241T3 (da) 2004-04-05
ID24673A (id) 2000-07-27
UA68350C2 (en) 2004-08-16
CO4940405A1 (es) 2000-07-24
BG103917A (bg) 2000-07-31
DZ2544A1 (fr) 2003-02-08
HUP0002250A2 (hu) 2000-12-28
HRP980378A2 (en) 1999-04-30
DE69820608D1 (de) 2004-01-29
NO996492L (no) 2000-02-29
TR199903282T2 (xx) 2000-08-21
PT980241E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
AP9801281A0 (en) Sertraline salts and sustained-release dosage forms of sertraline
HU9403071D0 (en) Potentiation of drug response
DE19681727T1 (de) Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
HUP0105107A2 (en) Fast dispersing dosage forms free of gelatin
HUP0000759A3 (en) Dosage forms comprising separate portions of r- and s-enantiomers
HUT75246A (en) Soft gelatin pharmaceutical dosage form
SI0948541T1 (sl) PTHrP analogi
SG54525A1 (en) Multiphase soft gelatin dosage form
IL152304A0 (en) Delayed-release dosage forms of sertraline
HUP0002250A3 (en) Gelatine encapsulated solution dosage forms of sertraline
SI0980241T1 (en) Gelatine encapsulated solution dosage forms of sertraline
DE9414607U1 (de) Parfümkapsel
ZA948357B (en) Potentiation of drug response
ZA985707B (en) Sertraline salts and sustained-release dosage forms of sertraline.
GB9703750D0 (en) Treatment of haemorrhoids
HU9701917D0 (en) New compound of medicinal activity
AUPM590295A0 (en) Manufacture of pharmaceutical dosage forms
TW313845U (en) Improved structure of pacifier
BR9504107A (pt) Encapsulamento de peças anatômicas
TW314782U (en) Improved structure of mask
UA1951S (uk) Етикетка медичного препарату "валідол"